References
- Dye C, Williams BG. The population dynamics and control of tuberculosis. Science328(5980), 856–861 (2010).
- Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int. J. Epidemiol.22(6), 1154–1158 (1993).
- Sterne JA, Rodrigues LC, Guedes IN. Does the efficacy of BCG decline with time since vaccination? Int. J. Tuberc. Lung Dis.2(3), 200–207 (1998).
- Hesseling AC, Johnson LF, Jaspan H et al. Disseminated bacille Calmette–Guérin disease in HIV-infected South African infants. Bull. World Health Organ.87(7), 505–511 (2009).
- Xing Z, Charters TJ. Heterologous boost vaccines for bacillus Calmette–Guérin prime immunization against tuberculosis. Expert Rev. Vaccines.6(4), 539–546 (2007).
- McShane H. Tuberculosis vaccines: beyond bacille Calmette–Guérin. Philosoph. Trans. Royal Soc. London366(1579), 2782–2789 (2011).
- Yang C, He YL, Zhang L et al. GLS/IL-12-modified Mycobacterium smegmatis as a novel anti-tuberculosis immunotherapeutic vaccine. Int. J. Tuberc. Lung Dis.13(11), 1360–1366 (2009).
- Sweeney KA, Dao DN, Goldberg MF et al. A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis. Nat. Med.17(10), 1261–1268 (2011).
- Orme IM, Collins FM. Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients. J. Exp. Med.158(1), 74–83 (1983).
- Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev.8(4), 247–258 (2008).
- Kaveh DA, Bachy VS, Hewinson RG, Hogarth PJ. Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 T(EM) cells which expand following virulent mycobacterial challenge. PloS ONE6(6), e21566 (2011).
- Bansal A, Jackson B, West K et al. Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus Type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration. J. Virol.82(13), 6458–6469 (2008).
- Wang J, Thorson L, Stokes RW et al. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J. Immunol.173(10), 6357–6365 (2004).
- Santosuosso M, McCormick S, Zhang X, Zganiacz A, Xing Z. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis. Infect. Immun.74(8), 4634–4643 (2006).
- Garcia-Contreras L, Wong YL, Muttil P et al. Immunization by a bacterial aerosol. Proc. Natl Acad. Sci. USA105(12), 4656–4660 (2008).
- Cooper AM. T cells in mycobacterial infection and disease. Curr. Opin. Immunol.21(4), 378–384 (2009).
- Walker KB, Brennan MJ, Ho MM et al. The second Geneva consensus: recommendations for novel live TB vaccines. Vaccine28(11), 2259–2270 (2010).